Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
15.30
-0.66 (-4.14%)
Oct 13, 2026, 4:00 PM EDT - Market closed
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $2.86 billion as of October 13, 2026. It is the 5,219th most valuable company in the world and the 1,506th biggest in the United States. Its market cap has increased by 43.04% in one year.
Market Cap
2.86B
Enterprise Value
2.19B
1-Year Change
43.04%
Global Rank
Country Rank
#1,506 United States
Category
ChartMarket Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $2.86B, an increase of 261.50%. That is a compound annual growth rate of 23.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 2.86B | -11.22% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acadia Pharmaceuticals | 3.41B |
| Parabilis Medicines | 3.39B |
| Arcutis Biotherapeutics | 3.34B |
| Viking Therapeutics | 3.33B |
| Celcuity | 3.32B |
| Tarsus Pharmaceuticals | 3.21B |
| Denali Therapeutics | 3.11B |
| Arcus Biosciences | 3.11B |